Author
|
Year
|
Study design
|
Type of Surgery
|
Sample Size (Overall)
|
Follow-up Length
|
CMS
|
---|
PI
|
non PI
|
---|
Brown et al
|
2012
|
RCS
|
THA,TKA
|
Primary
|
688
|
1862
|
3 mo
|
71
|
Frisch et al
|
2017
|
RCS
|
THA,TKA
|
Primary
|
253
|
386
|
12 mo
|
35
|
Fleischman et al
|
2018
|
RCS
|
TKA
|
Primary
|
2124
|
7665
|
3 mo
|
35
|
Hart et al
|
2019
|
RCS
|
THA,TKA
|
Revision
|
540
|
1835
|
3,12 mo
|
52
|
Hernandez et al
|
2019
|
RCS
|
THA,TKA
|
Primary
|
3067
|
7214
|
3,12 mo
|
53
|
Calkins et al
|
2020
|
RCT
|
THA,TKA
|
Revision
|
223
|
234
|
3 mo
|
80
|
Driesman et al
|
2020
|
RCS
|
THA,TKA
|
Primary
|
1227
|
1159
|
3,12 mo
|
73
|
Slullitel et al
|
2020
|
RCS
|
THA,TKA,HRs
|
Primary
|
2268
|
2268
|
3 mo
|
67
|
- Abbreviations: PI Povidone-Iodine, RCT randomized controlled trials, RCS retrospective cohort study, THA total hip arthroplasty, TKA total knee arthroplasty, CMS Coleman Methodology Score